We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$51.8B
AUM Growth
+$865M
Cap. Flow
-$2.26B
Cap. Flow %
-4.35%
Top 10 Hldgs %
18.7%
Holding
3,596
New
316
Increased
1,401
Reduced
1,378
Closed
153

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$374M
2
ADBE icon
Adobe
ADBE
+$83.9M
3
MU icon
Micron Technology
MU
+$80.8M
4
MRK icon
Merck
MRK
+$52.9M
5
PSA icon
Public Storage
PSA
+$47.2M

Sector Composition

Rank Sector Weight
1 Technology 22.42%
2 Healthcare 12.48%
3 Financials 12.36%
4 Consumer Discretionary 9.83%
5 Industrials 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAJ
2701
DELISTED
Canon, Inc.
CAJ
$20.5K ﹤0.01%
778
+756
+3,436% +$19.9K
FDMT icon
2702
4D Molecular Therapeutics
FDMT
$587M
$20.3K ﹤0.01%
1,126
BLX icon
2703
Bladex Inc
BLX
$2.12B
$19.9K ﹤0.01%
904
+83
+10% +$1.59K
ESPR
2704
DELISTED
Esperion Therapeutics
ESPR
$19.8K ﹤0.01%
14,250
-7,289
-34% -$10.2K
REFI
2705
Chicago Atlantic Real Estate Finance
REFI
$263M
$19.8K ﹤0.01%
1,304
+894
+218% +$13K
EDIT icon
2706
Editas Medicine
EDIT
$445M
$19.6K ﹤0.01%
2,387
-94
-4% -$819
GBX icon
2707
The Greenbrier Companies
GBX
$1.43B
$19.6K ﹤0.01%
454
+119
+36% +$3.52K
CDTX
2708
DELISTED
Cidara Therapeutics
CDTX
$19.3K ﹤0.01%
855
TRMK icon
2709
Trustmark
TRMK
$2.77B
$19.2K ﹤0.01%
908
-4,903
-84% -$111K
PGEN icon
2710
Precigen
PGEN
$2.49B
$19K ﹤0.01%
16,556
BYND icon
2711
Beyond Meat
BYND
$214M
$19K ﹤0.01%
1,464
+20
+1% +$254
CRH icon
2712
CRH
CRH
$67.5B
$19K ﹤0.01%
340
-34,473
-99% -$1.72M
NUV icon
2713
Nuveen Municipal Value Fund
NUV
$1.9B
$18.7K ﹤0.01%
+2,151
New +$18.9K
FORG
2714
DELISTED
ForgeRock, Inc.
FORG
$18.6K ﹤0.01%
906
+722
+392% +$14.5K
LCII icon
2715
LCI Industries
LCII
$2.6B
$18.5K ﹤0.01%
146
+8
+6% +$916
UDMY
2716
DELISTED
Udemy
UDMY
$18.2K ﹤0.01%
+1,700
New +$16.2K
JANX icon
2717
Janux Therapeutics
JANX
$1.01B
$18.2K ﹤0.01%
1,532
RYTM icon
2718
Rhythm Pharmaceuticals
RYTM
$7.89B
$18.1K ﹤0.01%
+1,100
New +$19.9K
VIR icon
2719
Vir Biotechnology
VIR
$1.5B
$18.1K ﹤0.01%
737
-1,963
-73% -$49.3K
AZZ icon
2720
AZZ Inc
AZZ
$4.65B
$17.7K ﹤0.01%
408
WKHS icon
2721
Workhorse Group
WKHS
$33.9M
$17.7K ﹤0.01%
7
+3
+75% +$8.66K
AOMR
2722
Angel Oak Mortgage REIT
AOMR
$210M
$17.6K ﹤0.01%
2,130
CLB icon
2723
Core Laboratories
CLB
$568M
$17.5K ﹤0.01%
754
FBIO icon
2724
Fortress Biotech
FBIO
$87.4M
$17.2K ﹤0.01%
2,080
MCS icon
2725
Marcus Corp
MCS
$916M
$17.1K ﹤0.01%
1,152

Similar funds

Russell Investments Group's Q2 2023 Portfolio in Review

As of Q2 2023, Russell Investments Group held 3,596 positions worth $51.8B, up 1.7% from $51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Russell Investments Group withdrew a net $2.26B in Q2 2023, closing 153 positions and reducing 1,378 holdings. Its most notable exit was Momentive Global Inc. Common Stock, an estimated $25.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Russell Investments Group opened a new position in iShares MSCI USA Min Vol Factor ETF worth $34.5M.

  • Russell Investments Group's largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 464,056 shares worth $34.5M.
  • Russell Investments Group added most to NVIDIA in Q2 2023, an estimated $138M increase.
  • Russell Investments Group's biggest Q2 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $374M.
  • Russell Investments Group fully exited Momentive Global Inc. Common Stock in Q2 2023, selling an estimated $25.6M.
  • Russell Investments Group's ten largest holdings make up 19% of its $51.8B portfolio in Q2 2023.
  • Russell Investments Group opened 316 new positions and closed 153 in Q2 2023.
  • Russell Investments Group's portfolio value rose 1.7% quarter-over-quarter to $51.8B.

Based on Russell Investments Group's 13F filing for Q2 2023, filed 10 Aug 2023.